Hajrul Yahood Bhasma
Hajrul Yahood Bhasma is a bhasma, a mineral or metal preparation reduced to ash by repeated calcination. Kidney stones (Ashmari): Lithontriptic and diuretic activity confirmed in research.
| Substance type | Mineral or metal preparation, not a plant |
|---|---|
| Also known as | Hajrul Yahood Bhasma, HajrulYahoodBhasma |
Names and identification
| Language | Name |
|---|---|
| English | Hajrul Yahood Bhasma |
Key Phytochemical Constituents
- Calcium silicate (CaSiO3) as primary constituent
- Calcium oxide (CaO) from thermal decomposition
- Silicon dioxide (SiO2)
- Trace magnesium, iron, aluminum
- Organic compounds from radish/herbal trituration media
How does it work?
- Lithontriptic (stone-dissolving) action through calcium silicate-mediated chemical dissolution of calcium oxalate and calcium phosphate kidney stones
- Diuretic action through osmotic and ionic mechanisms, increasing urinary volume and flow to facilitate stone passage from kidneys through ureters
- Anodyne (pain-relieving) action reducing renal colic, observed clinically within 2-3 doses, likely through smooth muscle relaxation in urinary tract
- Gastroprotective effect through acid neutralization and mucosal protection, demonstrated in clinical trial showing 72% ulcer healing rate
Which traditional uses are supported by research?
- Kidney stones (Ashmari): Lithontriptic and diuretic activity confirmed in research. Anodyne action reducing renal colic within 2-3 doses validated clinically.
- Gastric ulcers: Clinical trial showed 72% ulcer-healing rate with Hajrul Yahood + licorice vs 45% with ranitidine, validating gastroprotective use
- Dysuria and urinary disorders: Diuretic and smooth muscle relaxant properties support traditional use for painful urination (Mutrakrichra)
What do recent clinical trials show?
3 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- RELATIVELY SAFE: Calcium silicate-based preparation without toxic heavy metals. Lower risk profile compared to metallic Bhasmas.
- CLINICAL EVIDENCE: Clinical trial data available showing therapeutic efficacy, a rarity among Bhasma preparations
- KIDNEY FUNCTION MONITORING: Long-term use should include periodic kidney function assessment, especially in patients with pre-existing renal conditions
- DRUG INTERACTIONS: May interact with antibiotics (tetracyclines, fluoroquinolones) and other calcium-binding drugs. Spacing of administration recommended.
What is it made of?
Mineral/Elemental Profile
- Calcium carbonate (CaCO3): Major component (fossil limestone)
- Calcium (Ca): ~35%
- Silicon (Si): Trace
- Magnesium (Mg): Trace
Analytical Methods: XRD, FTIR, ICP-OES, SEM
Dosage forms and preparation
Dosage Forms: Bhasma, Pishti
Standard Dosage: 250–500 mg twice daily
Bioavailability: Good; calcium carbonate form readily absorbed
Optimal Timing: With meals; with Shilajit or Gokshura for urinary disorders
Standardized Extract: Calcined calcium carbonate (fossil stone) bhasma
Shelf Life: Indefinite
Storage: Airtight, dry container
Marker Compounds: Calcium carbonate, Calcium phosphate, Silica
Quality Parameters: Calcium >30%, standard bhasma tests, no free calcium oxide
Vehicle (Anupana): Honey, Gokshuradi Kwatha, or Varuna Kwatha for urinary calculi
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.